Clinical Trials – Traditional Model To view page on mobile device, activate QR Code above Recruiting Cancer Clinical Trials at Salinas Valley Health CCTG MA.39 – Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (TAILOR RT)May 6, 2022 NRG-GI008 – Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)February 23, 2023 A012103 – Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabAugust 3, 2023 S2212 – Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III StudyFebruary 7, 2024 NRG-BR009 – Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)March 13, 2024 National Cancer Institute “Cancer Moonshot Biobank”January 13, 2025 NRG-CC015: Harnessing E-Mindfulness Approaches for Living After Breast Cancer (HEAL-ABC)June 30, 2025
